Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 11
March 14 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

MYELOID NEOPLASIA
CDK9 and mTOR: trading places
Katherine L. B. Borden
View Articletitled, CDK9 and mTOR: trading places
Lymphoid Neoplasia
Intricacies of CLL cytogenetic complexity
Lynne V. Abruzzo
View Articletitled, Intricacies of CLL cytogenetic complexity

PLENARY PAPER

MYELOID NEOPLASIA
Identification and targeting of novel CDK9 complexes in acute myeloid leukemia
Elspeth M. Beauchamp,Sameem M. Abedin,Sara G. Radecki,Mariafausta Fischietti,Ahmet Dirim Arslan,Gavin T. Blyth,Angela Yang,Connor Lantz,Alissa Nelson,Young Ah Goo,Imo Akpan,Elizabeth A. Eklund,Olga Frankfurt,Eleanor N. Fish,Paul M. Thomas,Jessica K. Altman,Leonidas C. Platanias
View Articletitled, Identification and targeting of novel CDK9 complexes in acute myeloid leukemia
Supplemental data

BLOOD SPOTLIGHT

Kaposi sarcoma–associated herpesvirus/human herpesvirus 8–associated lymphoproliferative disorders
Eric Oksenhendler,David Boutboul,Lionel Galicier
View Articletitled, Kaposi sarcoma–associated herpesvirus/human herpesvirus 8–associated lymphoproliferative disorders

HOW I TREAT

How I treat refractory chronic graft-versus-host disease
Clinical Trials & Observations
Stefanie Sarantopoulos,Adela R. Cardones,Keith M. Sullivan
View Articletitled, How I treat refractory chronic graft-versus-host disease
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma
Clinical Trials & Observations Brief Report
Peter Martin,Nancy L. Bartlett,Kristie A. Blum,Steven Park,Kami Maddocks,Jia Ruan,LeAnn Ridling,Christopher Dittus,Zhengming Chen,Xiangao Huang,Giorgio Inghirami,Maurizio DiLiberto,Selina Chen-Kiang,John P. Leonard
View Articletitled, A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

LYMPHOID NEOPLASIA

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas,Sabine Jeromin,Michalis Iskas,Anna Puiggros,Karla Plevova,Florence Nguyen-Khac,Zadie Davis,Gian Matteo Rigolin,Andrea Visentin,Aliki Xochelli,Julio Delgado,Fanny Baran-Marszak,Evangelia Stalika,Pau Abrisqueta,Kristina Durechova,George Papaioannou,Virginie Eclache,Maria Dimou,Theodoros Iliakis,Rosa Collado,Michael Doubek,M. Jose Calasanz,Neus Ruiz-Xiville,Carolina Moreno,Marie Jarosova,Alexander C. Leeksma,Panayiotis Panayiotidis,Helena Podgornik,Florence Cymbalista,Achilles Anagnostopoulos,Livio Trentin,Niki Stavroyianni,Fred Davi,Paolo Ghia,Arnon P. Kater,Antonio Cuneo,Sarka Pospisilova,Blanca Espinet,Anastasia Athanasiadou,David Oscier,Claudia Haferlach,Kostas Stamatopoulos,on behalf of ERIC, the European Research Initiative on CLL
View Articletitled, Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Supplemental data
High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma
Brief Report
Anjan Thakurta,Maria Ortiz,Pedro Blecua,Fadi Towfic,Jill Corre,Natalya V. Serbina,Erin Flynt,Zhinuan Yu,Zhihong Yang,Antonio Palumbo,Meletios A. Dimopoulos,Norma C. Gutierrez,Hartmut Goldschmidt,Pieter Sonneveld,Herve Avet-Loiseau
View Articletitled, High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands
Qiaozhi Wei,Philip E. Boulais,Dachuan Zhang,Sandra Pinho,Masato Tanaka,Paul S. Frenette
View Articletitled, Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands
Supplemental data

THROMBOSIS AND HEMOSTASIS

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications
Katherine J. Kearney,Nikoletta Pechlivani,Rhodri King,Christian Tiede,Fladia Phoenix,Ramsah Cheah,Fraser L. Macrae,Katie J. Simmons,Iain W. Manfield,Kerrie A. Smith,Benjamin E. J. Spurgeon,Khalid M. Naseem,Robert A. S. Ariens,Michael J. McPherson,Darren C. Tomlinson,Ramzi A. Ajjan
View Articletitled, Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications
Supplemental data
Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans
Dafna Groeneveld,David Pereyra,Zwanida Veldhuis,Jelle Adelmeijer,Petra Ottens,Anna K. Kopec,Patrick Starlinger,Ton Lisman,James P. Luyendyk
View Articletitled, Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans
Supplemental data

LETTERS TO BLOOD

Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma
Clinical Trials & Observations
Kosei Matsue,Yoshiaki Abe,Akihiro Kitadate,Daisuke Miura,Kentaro Narita,Hiroki Kobayashi,Masami Takeuchi,Naoko Enzan,Atsushi Tanaka,Kengo Takeuchi
View Articletitled, Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma
Supplemental data
Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity
Livia Weijenborg Campos,Priscila Pini Zenatti,Leonardo Granato Pissinato,Gisele O. Libanio Rodrigues,Leonardo Luís Artico,Thais Rafael Guimarães,Leticia Fröhlich Archangelo,Leandro Martínez,Andrew J. Brooks,José Andrés Yunes
View Articletitled, Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity
Supplemental data

BLOOD WORK

Hairy cell leukemia coexistent with chronic lymphocytic leukemia
Ivo M. B. Francischetti,Katherine R. Calvo
View Articletitled, Hairy cell leukemia coexistent with chronic lymphocytic leukemia
Mixed-phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1–rearranged
Huifei Liu
View Articletitled, Mixed-phenotype acute leukemia with t(4;11)(q21;q23) <em>KMT2A-AFF1</em>–rearranged
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement